key points of 3rd quarter (11/8/2012) results for CBPO
CBPO net income for 9 months,up 190% from 9 months one year ago, at $$1.52/share. On a yearly basis thats $2/share net income. Gross income for 9 months up 28% from one year ago.
Company has an array of over 30 products being developed. Sales volume of newer product, was up 44% from 3rd quarter,one year ago.
Taking $2/share net income per year, times PE of 8, gives you $16/ share price.
PE of 8 is low, considering the well managed company is growing at a rate of mid to high teens per year.
Considering promise of CBPO's product IVIG, based on Baxter trials, to help on Alzheimers Disease, CBPO's price could go to $20/share plus.